Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choline alfoscerate vs citicoline in elderly patients with post-stroke cognitive impairment
2017-000762-29Phase 3Completed
- Sponsor
- MDM Pharma
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in vascular cognitive disorder (VCD) comparing Delecit injection arm with Citicoline injection arm (2 arms). Primary endpoint: Global cognitive functions assessment. Started Jan 2021; status: completed.
02
Drugs
choline alfoscerateciticoline
03
Conditions
vascular cognitive disorder (VCD)
Beyond the preview
Go deeper on 2017-000762-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000762-29.